Keywords: cymevene, heart, transplants, administration, syntex, ganciclovir, prophylactic

CYMEVENE AND HEART TRANSPLANTS

Article | 11 May 1992

Print This

Administration of Syntex' Cymevene (ganciclovir) as a prophylactic to patients after they have received a heart transplant has been found ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in